Arcturus Therapeutics In...

NASDAQ: ARCT · Real-Time Price · USD
19.48
0.25 (1.30%)
At close: Aug 15, 2025, 3:59 PM
19.17
-1.62%
After-hours: Aug 15, 2025, 07:54 PM EDT

Arcturus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
237.03M 292M 391.88M 370.49M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
1.89M 1.89M 2.09M 515K
Other Long-Term Assets
n/a n/a n/a 2.08M
Receivables
3.97M 32.06M 2.76M 3.37M
Inventory
n/a n/a n/a n/a
Other Current Assets
64.98M 55M 8.69M n/a
Total Current Assets
305.98M 386.59M 403.33M 378.96M
Property-Plant & Equipment
36.2M 40.93M 44.96M 11.26M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
38.09M 42.81M 47.05M 13.85M
Total Assets
344.07M 429.4M 450.39M 392.81M
Account Payables
7.19M 5.28M 7.45M 10.06M
Deferred Revenue
21.93M 47.34M 36.12M 43.48M
Short-Term Debt
3.55M n/a 60.66M 22.47M
Other Current Liabilities
3.89M 18.5M n/a 18.41M
Total Current Liabilities
65.49M 81.99M 126.98M 99.54M
Long-Term Debt
n/a n/a n/a 40.63M
Other Long-Term Liabilities
n/a 497K 2.8M 19.93M
Total Long-Term Liabilities
37.6M 68.9M 53.09M 65.07M
Total Liabilities
103.09M 150.89M 180.07M 164.6M
Total Debt
28.55M 30.22M 94.75M 69.15M
Common Stock
27K 27K 27K 26K
Retained Earnings
-448.81M -367.87M -338.14M -347.49M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
240.98M 278.51M 270.31M 228.21M
Total Investments
1.89M 1.89M 2.09M 515K